gi197845
3年前
You're missing the fact that Dr.Wiess is a conman. All he could say, when I called his cell number and confronted him, was "call me tomorrow."
OVI-123 was fungus that literally grew on cow manure.
OVI-117 was a bust as well.
So much for curing colon-cancer.
Wash, rinse and repeat these types of OTC pink sheet con-jobs!
If it's not a reverse split that gets ya, it will be FDA rejection, or a shelf-offering with billions of diluted shares!
The stock market casino!
BTW, how much did you lose? Was it your entire life's savings? Are you too old to make back the losses? How do you like the inflation and wars? Better worry about cyclical global warming, it's our biggest threat...Ya right!
m_a_d
3年前
Whether on not a stock can come back from the grey market is a moot point for $OVIT. There has to be someone trying to bring it back. In this case (as well as for COHG, CHME, and ZHUD, and others I'm not invested in) OMNI has thrown in the towel and asked the court to rescind the Custodian request.
This (and the others) is most likely a dead ticker, never to be heard from again.
Please don't think I'm bashing the stock to buy more, this one going down on its own. Between the 4 tickers, I've lost close to $35k. That's why I spread my money around and never YOLO a ticker.
Skeetz99
3年前
If an expert market security submits all filing tomorrow, they can be quoted the next day after review. This list is updated daily to FINRA. Do your homework before making assumptions. This amendment to the new rules happened on 9/17, its why I held everything
9:27 PM · Sep 27, 2021·Twitter for iPhone
FORM 211
General Instructions
Complete this form to initiate or resume quotations in a quotation medium, as defined in Rule 15c2-
11(e)(i) under the Securities Exchange Act of 1934 (1934 Act) including, but not limited to, the OTC
Bulletin BoardTM or OTC Link® ATS. By completing this form, your firm is representing that it has satisfied
all applicable requirements of Rule 15c2-11 and the filing and information requirements of FINRA Rule
6432. It is not necessary to file this application if a member qualifies for an exception or exemption
provided by paragraphs (f)(1)-(5) or (h) of Rule 15c2-11.
Send the completed form and a copy of the required Issuer information to FINRA, OTC Compliance Unit,
9509 Key West Avenue, Rockville, MD 20850-3329. If you have any questions, call the OTC Compliance
Unit at (240) 386-5100.
Check the applicable quotation medium(s):
? OTC Bulletin BoardTM
? OTC Link® ATS
? Other (name of quotation medium)
gi197845
3年前
OminCorp failed to secure the reverse shell merger of OVIT, due to Dr.Alexander Weis, CEO not willing to sell even 1 share for a profit. He's still claiming to cure colon cancer with OVI-123, which he lost that patent on and even then, it was knly a fungus that grew on cow flop/patties! If you call Dr.Wies and ask him a direct question, all he'll see is..."Call me back tomorrow." as is something is in progress, then if you call him back the very next day, he'll say the same thing, "call me back tomorrow..."